J Seth Strattan PhD
Investing Profile
Two Bear Capital thesis
Abilita Therapeutics Abilita Therapeutics enables discovery of novel therapeutics for previously undruggable membrane protein targets. Abilita Therapeutics enables discovery of novel therapeutics for previously undruggable membrane protein targets. About the company Abilita Therapeutics on LinkedIn Abilita Therapeutics website Abilita Therapeutics is a biotech company specializing in discovering and developing therapies for the most challenging membrane proteins, including GPCRs, ion channels and transporters. Despite their high significance, hundreds of such drug targets remain untapped. Abil
Sector and stage focus
- Seed: Material Science, Medical Devices, Pharmaceuticals, Developer Tools, Cloud Infrastructure, BioTech, AI, Cybersecurity, Drug Delivery, Health IT
- Series B: AI, Developer Tools, BioTech, Cloud Infrastructure, Medical Devices, Material Science, Pharmaceuticals, Cybersecurity, Drug Delivery, Health IT
- Series A: Developer Tools, Cloud Infrastructure, Medical Devices, Material Science, Pharmaceuticals, BioTech, Health IT, AI, Drug Delivery, Cybersecurity
- general: Investors who invested in female founders, Investors who invested in diverse founders, San Francisco Bay Area
Recent investments by J Seth Strattan PhD
J Seth Strattan PhD has 4 named past investments in the public record. The most recent:
| Company | Stage | Date | Round size |
|---|---|---|---|
| Elisity | Series A | Jun 2021 | $26M |
| TileDB | Series A | Jul 2020 | $15M |
| Inimmune | Series A | Jul 2020 | $22M |
| Graphiant | Series A | Dec 2020 | $34M |
Frequent co-investors
J Seth Strattan PhD has co-invested with: Bill Coughran.
Is J Seth Strattan PhD a fit for your round?
Upload your pitch deck and see whether J Seth Strattan PhD appears in your top 20 matches.
Find investors for your deck